Amneal

Generic drug issues.

Based in NJ

🤖

AI Overview

With $340K in lobbying spend across 7 quarterly filings, Amneal is an active lobbying client. They deploy 19 individual lobbyists Their lobbying covers 3 issue areas. Active from 2020 to 2022.

$340K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2020	$60K
2021	$240K
2022	$40K

Issues Lobbied

Health Issues Pharmacy Manufacturing

Lobbying Firms

Mehlman Consulting, INC.

Lobbyists

Dean Rosen David Thomas Elise Finley Pickering David Castagnetti Bruce Mehlman Steve Haro Sage Eastman Lauren Aronson Michael Robinson Constantine Hingson Helen Tolar Nichole Distefano Mckenzie Brice Paul Thornell Stephen Cote Alexander Perkins Victoria Flood Rosemary Gutierrez Zachary Mallove

Government Agencies Targeted

These are the government entities that Amneal disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEFood & Drug Administration (FDA)Health & Human Services, Dept of (HHS)White House Office

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy, Manufacturing

Generic drug issues.

Monitoring legislative and regulatory efforts related to domestic manufacturing of generic drugs.

Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs.